Skeletal muscle-targeted peptide MSP
Rif. 3D-CRB1001632
| 1mg | 284,00 € | ||
| 500µg | 207,00 € |
Informazioni sul prodotto
- H-ASSLNIA-OH
Gene therapy is potentially an ideal treatment for muscle tissue myopathies but targeting remains an issue. The large volume of muscle in the body versus the requirement for tissue-specificity is of particular concern. This heptapeptide has been shown to preferentially bind skeletal myofibers and thus can be used to study targeting of peptide/gene-delivery to muscle tissue. Research into gene therapy of Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA) has been of particular interest with muscle targeting peptides. This product already shows ideal placement to continue that research to overcome some of these issues.
Proprietà chimiche
Richiesta tecnica su: 3D-CRB1001632 Skeletal muscle-targeted peptide MSP
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
